Lv4
408 积分 2025-03-26 加入
Once‐daily vs twice‐daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible: A randomized trial
25天前
已完结
Once‐daily vs twice‐daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible: A randomized trial
29天前
已完结
A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years1
29天前
已关闭
Tacrolimus versus ciclosporin immunosuppression: long-term outcome in renal transplantation
29天前
已完结
Once‐daily vs twice‐daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible: A randomized trial
30天前
已完结
Long‐term, prolonged‐release tacrolimus‐based immunosuppression in de novo kidney transplant recipients: 5‐year prospective follow‐up of the ADHERE study patients
1个月前
已完结
Randomized trial of 3 maintenance regimens (TAC/SRL vs. TAC/MMF vs. CSA/SRL) with low‐dose corticosteroids in primary kidney transplantation: 18‐year results
1个月前
已完结
Long term follow-up of the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial
1个月前
已完结
Efficacy and Safety of Simnotrelvir-Ritonavir Compared With Nirmatrelvir-Ritonavir in the Treatment of COVID-19: Real-World Evidence From a Retrospective Cohort Study During the Prevalence of the Omicron EG.5 Variant
2个月前
已完结
Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
4个月前
已完结
皖公网安备34019202002308
